Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
作者信息
Monnet Dominique L, Harbarth Stephan
机构信息
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
出版信息
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2001886.
Abstract
摘要
相似文献
1
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?冠状病毒病（COVID-19）会对抗菌素耐药性产生影响吗？
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2001886.
2
Tackling antimicrobial resistance in the COVID-19 pandemic.应对新冠疫情中的抗菌药物耐药性问题。
Bull World Health Organ. 2020 Jul 1;98(7):442-442A. doi: 10.2471/BLT.20.268573.
3
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
4
COVID-19 will further exacerbate global antimicrobial resistance.新型冠状病毒肺炎将进一步加剧全球抗菌药物耐药性。
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
5
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
6
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
7
Antimicrobial stewardship: a COVID casualty?抗菌药物管理：新冠疫情的牺牲品？
J Hosp Infect. 2020 Nov;106(3):401-403. doi: 10.1016/j.jhin.2020.10.002. Epub 2020 Oct 9.
8
Protection and disinfection policies against SARS-CoV-2 (COVID-19).针对严重急性呼吸综合征冠状病毒2（新冠病毒）的防护与消毒政策。
Infez Med. 2020;28(2):185-191.
9
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
10
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
引用本文的文献
1
Influence of COVID-19 pandemic on the distribution and drug resistance of pathogens in patients with bloodstream infection.新型冠状病毒肺炎大流行对血流感染患者病原体分布及耐药性的影响
Front Public Health. 2025 Jul 28;13:1607801. doi: 10.3389/fpubh.2025.1607801. eCollection 2025.
2
Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents.抗生素自我药疗的分布及影响因素：一项针对中国居民的横断面研究
Antibiotics (Basel). 2025 Jul 12;14(7):701. doi: 10.3390/antibiotics14070701.
3
Carbapenem-Resistant Gram-Negative Bacteria in Hospitalized Patients: A Five-Year Surveillance in Italy.意大利住院患者中耐碳青霉烯类革兰阴性菌：一项为期五年的监测
Infect Dis Rep. 2025 Jul 2;17(4):76. doi: 10.3390/idr17040076.
4
Emergence of carbapenem-resistant clonal complex 2 in multiple hospitals in São Paulo state, Brazil.巴西圣保罗州多家医院中耐碳青霉烯类的克隆复合体2的出现。
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0186524. doi: 10.1128/aac.01865-24. Epub 2025 Jul 23.
5
Impact of the COVID-19 pandemic on the consumption of antibiotics and the emergence of AMR: case study in a general hospital.新冠疫情对抗生素使用及抗菌药物耐药性产生的影响：一家综合医院的案例研究
Front Public Health. 2025 Jun 23;13:1584574. doi: 10.3389/fpubh.2025.1584574. eCollection 2025.
6
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.新型冠状病毒肺炎大流行对抗菌药物使用的影响：一项国际患者水平队列研究。
JAC Antimicrob Resist. 2025 Mar 26;7(2):dlaf037. doi: 10.1093/jacamr/dlaf037. eCollection 2025 Apr.
7
Evaluation of Secondary Bacterial Infections and Determination of Antibiogram Susceptibility Testing in Hospitalized Patients with COVID-19.新冠病毒肺炎住院患者继发性细菌感染的评估及药敏试验的测定
Iran J Pathol. 2024 Fall;19(4):392-399. doi: 10.30699/IJP.2024.2006587.3141. Epub 2024 Oct 2.
8
Extended-Spectrum β-Lactamase-Producing Enterobacterales in Municipal Wastewater Collections, Switzerland, 2019-2023.2019 - 2023年瑞士城市污水收集系统中产生超广谱β-内酰胺酶的肠杆菌科细菌
Emerg Infect Dis. 2025 Mar;31(3):574-578. doi: 10.3201/eid3103.240099.
9
Changes in incidence and epidemiology of antimicrobial resistant pathogens before and during the COVID-19 pandemic in Germany, 2015-2022.2015 - 2022年德国新冠疫情之前及期间抗菌药物耐药病原体的发病率和流行病学变化
BMC Microbiol. 2025 Jan 28;25(1):51. doi: 10.1186/s12866-024-03723-5.
10
The impact of the COVID-19 pandemic on the antimicrobial stewardship workforce in Scottish acute care hospitals-a qualitative study.新冠疫情对苏格兰急症医院抗菌药物管理工作队伍的影响——一项定性研究
JAC Antimicrob Resist. 2024 Dec 12;6(6):dlae199. doi: 10.1093/jacamr/dlae199. eCollection 2024 Dec.
本文引用的文献
1
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant in Europe, 2019.2019 年欧洲耐碳青霉烯类肠杆菌科细菌的流行病学情况、实验室能力和应对准备情况。
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2001735.
2
Enabling appropriate use of antibiotics: review of European Union procedures of harmonising product information, 2007 to 2020.促进抗生素的合理使用：欧盟协调产品信息程序的回顾，2007 年至 2020 年。
Euro Surveill. 2020 Nov;25(45). doi: 10.2807/1560-7917.ES.2020.25.45.2000035.
3
Impact of COVID-19 response on global surgical volumes: an ongoing observational study.新冠疫情应对措施对全球手术量的影响：一项正在进行的观察性研究。
Bull World Health Organ. 2020 Oct 1;98(10):671-682. doi: 10.2471/BLT.20.264044. Epub 2020 Sep 3.
4
Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.COVID-19 预防措施对医疗保健相关性艰难梭菌感染风险的影响。
Am J Infect Control. 2021 May;49(5):640-642. doi: 10.1016/j.ajic.2020.09.010. Epub 2020 Oct 5.
5
Impact of COVID-19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time-series analysis.2019冠状病毒病对苏格兰事故与急诊就诊以及急诊和计划住院的影响：一项中断时间序列分析
J R Soc Med. 2020 Nov;113(11):444-453. doi: 10.1177/0141076820962447. Epub 2020 Oct 4.
6
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe.新型冠状病毒病 2019（COVID-19）疫情对欧洲各紧急和心脏病科急性入院的影响。
Am J Med. 2021 Apr;134(4):482-489. doi: 10.1016/j.amjmed.2020.08.043. Epub 2020 Sep 30.
7
Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.2018 年欧盟/欧洲经济区临床实验室信息向国家公共卫生监测系统自动数字化报告的调查结果。
Euro Surveill. 2020 Oct;25(39). doi: 10.2807/1560-7917.ES.2020.25.39.1900591.
8
Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients.新兴的共病原体：纽约市新冠肺炎患者中产生新德里金属β-内酰胺酶的肠杆菌科细菌感染
Int J Antimicrob Agents. 2020 Dec;56(6):106179. doi: 10.1016/j.ijantimicag.2020.106179. Epub 2020 Sep 25.
9
A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit.在一家重症监护病房内，与 COVID-19 患者相关的耐万古霉素肠球菌院内感染集群。
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):154. doi: 10.1186/s13756-020-00820-8.
10
Bacterial coinfections in COVID-19: an underestimated adversary.COVID-19 中的细菌合并感染：被低估的对手。
Ann Ist Super Sanita. 2020 Jul-Sep;56(3):359-364. doi: 10.4415/ANN_20_03_14.
Zotero 插件